Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
06/30/2020 07/01/2020 07/02/2020 07/03/2020 07/06/2020 Date
82.42(c) 82.81(c) 83.04(c) 82.38(c) 83.47(c) Last
4 845 029 4 443 238 4 634 938 2 548 821 3 205 026 Volume
-1.14% +0.47% +0.28% -0.79% +1.32% Change
More quotes
Financials (USD)
Sales 2020 50 069 M - -
Net income 2020 9 107 M - -
Net Debt 2020 17 461 M - -
P/E ratio 2020 22,2x
Yield 2020 3,52%
Sales 2021 53 187 M - -
Net income 2021 10 693 M - -
Net Debt 2021 12 110 M - -
P/E ratio 2021 18,8x
Yield 2021 3,66%
Capitalization 195 B 195 B -
EV / Sales 2020 4,25x
EV / Sales 2021 3,90x
Nbr of Employees 109 000
Free-Float 84,4%
More Financials
Company
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical products (79.5%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.; - generic drugs (20.5%; Sandoz). Net sales... 
Sector
Pharmaceuticals
Calendar
07/21Earnings Release
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVARTIS AG
07/03NOVARTIS : resolves legacy litigation matters, finalizing settlement of speaker ..
AQ
07/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/02NOVARTIS : resolves legacy litigation matters, finalizing settlement of speaker ..
AQ
07/02NOVARTIS : Sandoz reviewing options after Federal Circuit upholds lower court ru..
AQ
07/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/02Novartis pays $729 million to settle U.S. kickback charges
RE
07/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/01NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/01NOVARTIS : agrees to pay $642M to settle False Claims Act charges
AQ
07/01NOVARTIS : pays $678M to resolve suit over sham doctor outings
AQ
07/01NOVARTIS : Finalizes Settlement of Speaker Program Litigation in U.S.--Update
DJ
07/01NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
News in other languages on NOVARTIS AG
01:46aNovartis erhält EU-Zulassung für Asthma-Mittel Enerzair Breezhaler
01:45aNOVARTIS : homologation en Europe d'un dispositif contre l'asthme
07/06Aktien Schweiz Schluss: Konjunkturoptimismus lenkt von Corona ab
07/06Bourse Zurich: la semaine débute sur une note positive
07/06Aktien Schweiz: Bullen gewinnen Oberhand und treiben SMI an
More news
Analyst Recommendations on NOVARTIS AG
More recommendations
Stock Trading Strategies
NOVARTIS AG - 06/16
The stock approaches again the support level
BUY
More Stock Trading Analysis
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 102,53 $
Last Close Price 88,61 $
Spread / Highest target 46,2%
Spread / Average Target 15,7%
Spread / Lowest Target -13,1%
EPS Revisions
Managers
NameTitle
Vasant Narasimhan Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Werner Kirsch Chief Financial Officer
John Tsai Chief Medical Officer
Elizabeth Theophille Chief Technology & Digital Officer
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG-9.17%195 408
JOHNSON & JOHNSON-3.36%371 399
ROCHE HOLDING AG4.71%295 898
MERCK & CO., INC.-12.50%198 849
PFIZER, INC.-11.92%191 697
ABBVIE INC.11.83%174 260